Experimental monoclonal antibodies show promise against Epstein-Barr virus

A panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV).

Strengthening the immune response to cancer

For patients with lymphoma, multiple myeloma, or certain types of leukemia, treatment with chimeric antigen.

Researchers seek to improve success of chimeric antigen receptor-T cell therapy

A study published by researchers from Mayo Clinic Cancer Center at Mayo Clinic in Florida.